MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immuneering (IMRX) Ownership - Who owns Immuneering?
Immuneering Corp is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
52.18M
P/E Ratio
N/A
Total Cash
36.14M
Projected Growth
N/A
Total Debt
4.16M
Revenue
N/A
Risk (Beta)
-0.59
Dividend Yield
N/A
Total Cash/Share
1.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMRX
Capitalization
52.2M
P/E Ratio
N/A
Risk (Beta)
-0.59
Dividend Yield
N/A
Total Cash
36.1M
Total Cash/Share
1.00
Total Debt
4.16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
41.4M
P/B Ratio
1.25
Cash Flow
N/A
Earnings
-2.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
5.28
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-63.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-78.61
Shares Held By Institutions
11.8M
Shares Outstanding - Current
36M
Total Liabilities
11.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
-34.091
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com